Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial JF Howard, V Bril, T Vu, C Karam, S Peric, T Margania, H Murai, ... The Lancet Neurology 20 (7), 526-536, 2021 | 256 | 2021 |
Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans G Hayashi, M Jasoliya, S Sahdeo, F Saccà, C Pane, A Filla, A Marsili, ... Human molecular genetics 26 (15), 2864-2873, 2017 | 103 | 2017 |
A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design F Sacca, G Puorro, A Antenora, A Marsili, A Denaro, R Piro, P Sorrentino, ... PLoS One 6 (3), e17627, 2011 | 79 | 2011 |
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests F Saccà, T Costabile, A Carotenuto, R Lanzillo, M Moccia, C Pane, ... Multiple Sclerosis Journal 23 (9), 1289-1296, 2017 | 66 | 2017 |
A randomized clinical trial of lithium in multiple system atrophy F Saccà, A Marsili, M Quarantelli, V Brescia Morra, A Brunetti, R Carbone, ... Journal of neurology 260, 458-461, 2013 | 46 | 2013 |
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2 F Saccà, G Puorro, A Brunetti, G Capasso, A Cervo, S Cocozza, ... Journal of neurology 262, 149-153, 2015 | 42 | 2015 |
The multiple faces of spinocerebellar ataxia type 2 A Antenora, C Rinaldi, A Roca, C Pane, M Lieto, F Saccà, S Peluso, ... Annals of Clinical and Translational Neurology 4 (9), 687-695, 2017 | 34 | 2017 |
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia M Jasoliya, F Sacca, S Sahdeo, F Chedin, C Pane, V Brescia Morra, ... PloS one 14 (6), e0217776, 2019 | 32 | 2019 |
Clinical use of frataxin measurement in a patient with a novel deletion in the FXN gene F Saccà, A Marsili, G Puorro, A Antenora, C Pane, A Tessa, ... Journal of neurology 260, 1116-1121, 2013 | 32 | 2013 |
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial J Palace, DM Wingerchuk, K Fujihara, A Berthele, C Oreja-Guevara, ... Multiple sclerosis and related disorders 47, 102641, 2021 | 31 | 2021 |
L ong‐term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia F Saccà, G Puorro, A Marsili, A Antenora, C Pane, C Casali, C Marcotulli, ... Movement Disorders 31 (5), 734-741, 2016 | 31 | 2016 |
Brain structure and degeneration staging in Friedreich ataxia: magnetic resonance imaging volumetrics from the ENIGMA‐ataxia working group IH Harding, S Chopra, F Arrigoni, S Boesch, A Brunetti, S Cocozza, ... Annals of Neurology 90 (4), 570-583, 2021 | 26 | 2021 |
Emotion recognition and psychological comorbidity in Friedreich’s ataxia T Costabile, V Capretti, F Abate, A Liguori, F Paciello, C Pane, A De Rosa, ... The Cerebellum 17, 336-345, 2018 | 24 | 2018 |
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review S Cocozza, G Pontillo, G De Michele, M Di Stasi, E Guerriero, T Perillo, ... Neuroradiology 63, 983-999, 2021 | 23 | 2021 |
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study S Cocozza, T Costabile, G Pontillo, M Lieto, C Russo, L Radice, C Pane, ... Journal of Neurology 267, 350-358, 2020 | 20 | 2020 |
Efficacy of innovative therapies in myasthenia gravis: a systematic review, meta‐analysis and network meta‐analysis F Saccà, C Pane, PE Espinosa, MP Sormani, A Signori European Journal of Neurology 30 (12), 3854-3867, 2023 | 19 | 2023 |
The use of medical-grade cannabis in patients non-responders to Nabiximols F Saccà, C Pane, A Carotenuto, M Massarelli, R Lanzillo, EB Florio, ... Journal of the neurological sciences 368, 349-351, 2016 | 15 | 2016 |
Overt hypogonadism may not be a sentinel sign of RING finger protein 216: Two novel mutations associated with ataxia, chorea, and fertility M Lieto, D Galatolo, A Roca, S Cocozza, G Pontillo, T Fico, C Pane, ... Movement disorders clinical practice 6 (8), 724, 2019 | 14 | 2019 |
Peripheral markers of autophagy in polyglutamine diseases G Puorro, A Marsili, F Sapone, C Pane, A De Rosa, S Peluso, ... Neurological Sciences 39, 149-152, 2018 | 14 | 2018 |
Normalization of timed neuropsychological tests with the PATA rate and nine‐hole pegboard tests F Saccà, T Costabile, F Abate, A Liguori, F Paciello, C Pane, A De Rosa, ... Journal of Neuropsychology 12 (3), 471-483, 2018 | 13 | 2018 |